PROGENICS PHARMACEUTICALS INC 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Oct 4, 2016
Insider Transaction Report
Form 4
Tenbarge Bryce
Vice President, Commercial
Transactions
- Award
Non-Qualified Stock Option (Right to Buy)
2016-10-03+75,000→ 75,000 totalExercise: $6.77Exp: 2026-10-03→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]5yr 20% On Vest beginning on 01-SEP-2016